Leading diagnostic chain Dr Lal PathLabs has filed draft red herring prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds through an IPO. The promoters and other existing shareholders will collectively sell 11.6 million shares of the company amounting to 14.1 per cent stake.

As per the DRHP, the IPO would be made through an Offer for Sale and the proceeds would be remitted to the respective promoters and other investors and therefore the company will not receive any proceeds from the offer.

Kotak Mahindra Capital and Citigroup Global Markets India are the book running lead managers for the IPO.

Dr Lalpathlabs is a pioneer diagnostic centre in India that provides blood test services. It is believed to be the most trusted pathology lab in the country.

Dr. Lal Pathlabs Share Price

2953.35 -67.15 (-2.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.